David Y Liu

USPTO Granted Patents = 108 (Patent Applications = 35)

CIPO Patents = 5 (Patent Applications = 25)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 3.9

ph-index = 21

Forward Citations = 1,522(Granted Patents)

Inventors with similar research interests:

Location History:

Walnut, CA (US) (1981)
Marietta, GA (US) (2010 - 2012)
South San Francisco, CA (US) (2013 - 2018)
Palo Alto, CA (US) (1992 - 2020)
San Diego, CA (US) (2013 - 2020)
Milpitas, CA (US) (2016 - 2021)
Pacifica, CA (US) (2021)
Amherst, NH (US) (2021)
Newark, CA (US) (2018 - 2023)
Houston, TX (US) (2019 - 2023)
San Francisco, CA (US) (2010 - 2024)

Company Filing History:

26 out of 40

Abbvie Stemcentrx LLC

patents

15 out of 21

Biological Dynamics, Inc.

patents

15 out of 32

Protagonist Therapeutics, Inc.

Toshiba International Corporation

patents

9. 2 out of 3

Asher Biotherapeutics, Inc.

Protaganist Therapeutics, Inc.

patent

12. 1 out of 22

Utility Trailer Manufacturing Company

Global Eagle Entertainment Inc.

patents

15. 6 out of 832,680

Other

patents

Years Active: 1981-2025

Loading Chart...

108 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12247072 - IL-21 polypeptides and targeted constructs (2025-03-11),

2. 12234300 - Conjugated hepcidin mimetics (2025-02-25),

3. 12122827 - IL-21 polypeptides and targeted constructs (2024-10-22),

4. 11884748 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2024-01-30),

5. 11841027 - Pump system control (2023-12-12),

6. 11840581 - α4β7 thioether peptide dimer antagonists (2023-12-12),

7. 11753443 - Conjugated hepcidin mimetics (2023-09-12),

8. 11199194 - Linear pump control (2021-12-14),

9. 11177571 - Phased array antenna with edge-effect mitigation (2021-11-16),

10. 11111272 - α4α7 peptide monomer and dimer antagonists (2021-09-07),

11. 11077203 - Anti-SEZ6 antibody drug conjugates and methods of use (2021-08-03),

12. 11033634 - Light chain variable regions (2021-06-15),

13. 10941183 - Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases (2021-03-09),

14. 10818379 - Methods and systems for analyte information processing (2020-10-27),

15. 10787490 - Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases (2020-09-29),

Title: The Innovative Journey of David Y Liu

Introduction: David Y Liu is a renowned inventor based in Palo Alto, California. His groundbreaking work in the field of technology has led to numerous patents and innovations that have shaped the industry.

Latest Patents: David Y Liu holds several patents in the areas of artificial intelligence, machine learning, and data analytics. His most recent patents focus on enhancing cybersecurity measures for cloud-based systems.

Career Highlights: With a background in computer science and engineering, David Y Liu has worked for leading tech companies in Silicon Valley. He has held key roles in research and development, contributing to the development of cutting-edge technologies.

Collaborations: Throughout his career, David Y Liu has collaborated with top researchers, engineers, and scientists to push the boundaries of innovation. His collaborative efforts have resulted in the creation of revolutionary products and solutions.

Conclusion: David Y Liu's passion for innovation and his dedication to pushing the limits of technology have solidified his reputation as a visionary inventor in the tech industry. His work continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.